Formula Growth’s ACV Auctions ACVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-252,643
Closed -$5.46M 119
2024
Q4
$5.46M Buy
252,643
+13,318
+6% +$269K 1.85% 8
2024
Q3
$4.87M Sell
239,325
-16,800
-7% -$310K 1.67% 13
2024
Q2
$4.67M Sell
256,125
-23,200
-8% -$417K 1.7% 15
2024
Q1
$5.24M Buy
279,325
+54,710
+24% +$857K 1.68% 14
2023
Q4
$3.4M Sell
224,615
-171,000
-43% -$2.51M 1.09% 29
2023
Q3
$6.01M Sell
395,615
-3,795
-1% -$61.6K 2.05% 6
2023
Q2
$6.9M Sell
399,410
-160,950
-29% -$2.46M 2.2% 6
2023
Q1
$7.23M Sell
560,360
-50,350
-8% -$550K 2.33% 3
2022
Q4
$5.01M Sell
610,710
-3,500
-0.6% -$29.2K 1.42% 19
2022
Q3
$4.42M Buy
+614,210
New +$4.88M 1.26% 24

Other funds holding ACVA

Formula Growth's ACVA Position: Q1 2025 in Review

Formula Growth sold out of ACV Auctions (ACVA) in Q1 2025, closing a stake of 252,643 shares — an estimated $5.46M sold.

Formula Growth first reported a position in ACVA in Q3 2022 and held it in 10 quarters. The position peaked at $7.23M in Q1 2023. 256 funds tracked by Wall St. Rank hold ACVA as of Q1 2025.

  • Formula Growth reported no remaining ACV Auctions position as of Q1 2025 after selling out during the quarter.
  • Formula Growth sold 252,643 ACV Auctions shares in Q1 2025, an estimated $5.46M.
  • Formula Growth first reported a position in ACV Auctions in Q3 2022 and held it in 10 quarters.
  • Formula Growth's ACV Auctions position peaked at $7.23M in Q1 2023.
  • 256 funds tracked by Wall St. Rank held ACV Auctions as of Q1 2025.

Based on Formula Growth's 13F filing for Q1 2025, filed 14 May 2025.